Medacta Group Sa Stock Analysis
| MEDGF Stock | USD 83.91 0.00 0.00% |
Medacta Group SA holds a debt-to-equity ratio of 0.669. Medacta Group's financial risk is the risk to Medacta Group stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Medacta Group's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Medacta Group's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Medacta Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Medacta Group's stakeholders.
For most companies, including Medacta Group, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Medacta Group SA, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Medacta Group's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Medacta Group's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Medacta Group is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Medacta Group to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Medacta Group is said to be less leveraged. If creditors hold a majority of Medacta Group's assets, the Company is said to be highly leveraged.
Medacta Group SA is fairly valued with Real Value of 83.91 and Hype Value of 83.91. The main objective of Medacta Group pink sheet analysis is to determine its intrinsic value, which is an estimate of what Medacta Group SA is worth, separate from its market price. There are two main types of Medacta Group's stock analysis: fundamental analysis and technical analysis.
The Medacta Group pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Medacta Group's ongoing operational relationships across important fundamental and technical indicators.
Medacta |
Medacta Pink Sheet Analysis Notes
About 70.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 23rd of May 2022. Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. Medacta Group operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1421 people.The quote for Medacta Group SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Medacta Group SA contact the company at 41 91 696 60 60 or learn more at https://www.medacta.com.Medacta Group SA Investment Alerts
| Medacta Group SA generated a negative expected return over the last 90 days | |
| About 70.0% of the company outstanding shares are owned by corporate insiders |
Medacta Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.17 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medacta Group's market, we take the total number of its shares issued and multiply it by Medacta Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Medacta Profitablity
The company has Profit Margin (PM) of 0.12 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15.Technical Drivers
In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medacta Group SA, as well as the relationship between them.Medacta Group SA Price Movement Analysis
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medacta Group middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medacta Group SA. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Medacta Group SA Debt to Cash Allocation
Many companies such as Medacta Group, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Medacta Group SA has accumulated 47.7 M in total debt with debt to equity ratio (D/E) of 0.67, which is about average as compared to similar companies. Medacta Group SA has a current ratio of 2.7, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medacta Group until it has trouble settling it off, either with new capital or with free cash flow. So, Medacta Group's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medacta Group SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medacta to invest in growth at high rates of return. When we think about Medacta Group's use of debt, we should always consider it together with cash and equity.Medacta Group Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Medacta Group's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Medacta Group, which in turn will lower the firm's financial flexibility.About Medacta Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Medacta Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medacta shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Medacta Group. By using and applying Medacta Pink Sheet analysis, traders can create a robust methodology for identifying Medacta entry and exit points for their positions.
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. Medacta Group operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1421 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Medacta Group to your portfolios without increasing risk or reducing expected return.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Complementary Tools for Medacta Pink Sheet analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |